Maher N, Mouhssine S, Matti B, Alwan A, Gaidano G
Cancers (Basel). 2025; 17(5).
PMID: 40075754
PMC: 11899122.
DOI: 10.3390/cancers17050907.
Xing Y, Tan C, Liu Z, Liu Y, Liu S, Wang G
J Nat Med. 2025; 79(2):399-411.
PMID: 39815148
PMC: 11880072.
DOI: 10.1007/s11418-024-01873-4.
Sarott R, Gourisankar S, Karim B, Nettles S, Yang H, Dwyer B
Science. 2024; 386(6717):eadl5361.
PMID: 39361741
PMC: 11629774.
DOI: 10.1126/science.adl5361.
Konstantakopoulou C, Verykokakis M
Adv Exp Med Biol. 2024; 1459:79-94.
PMID: 39017840
DOI: 10.1007/978-3-031-62731-6_4.
Krause R, Ogongo P, Tezera L, Ahmed M, Mbano I, Chambers M
Commun Biol. 2024; 7(1):584.
PMID: 38755239
PMC: 11099031.
DOI: 10.1038/s42003-024-06282-7.
Loss of CREBBP and KMT2D cooperate to accelerate lymphomagenesis and shape the lymphoma immune microenvironment.
Li J, Chin C, Ying H, Meydan C, Teater M, Xia M
Nat Commun. 2024; 15(1):2879.
PMID: 38570506
PMC: 10991284.
DOI: 10.1038/s41467-024-47012-1.
Germinal Center Dark Zone harbors ATR-dependent determinants of T-cell exclusion that are also identified in aggressive lymphoma.
Cancila V, Morello G, Bertolazzi G, Chan A, Bastianello G, Paysan D
Res Sq. 2024; .
PMID: 38562878
PMC: 10984086.
DOI: 10.21203/rs.3.rs-4093618/v1.
Interleukin-4 downregulates transcription factor BCL6 to promote memory B cell selection in germinal centers.
Shehata L, Thouvenel C, Hondowicz B, Pew L, Pritchard G, Rawlings D
Immunity. 2024; 57(4):843-858.e5.
PMID: 38513666
PMC: 11104266.
DOI: 10.1016/j.immuni.2024.02.018.
Selective deletion of E3 ubiquitin ligase FBW7 in VE-cadherin-positive cells instigates diffuse large B-cell lymphoma in mice in vivo.
Cai Z, You S, Liu Z, Song P, Zhao F, An J
Cell Death Dis. 2024; 15(3):212.
PMID: 38485719
PMC: 10940678.
DOI: 10.1038/s41419-024-06597-7.
Selectively targeting BCL6 using a small molecule inhibitor is a potential therapeutic strategy for ovarian cancer.
Wu M, Xie J, Xing Y, Zhang L, Chen H, Tang B
Int J Biol Sci. 2024; 20(2):486-501.
PMID: 38169532
PMC: 10758095.
DOI: 10.7150/ijbs.86303.
Mechanism and regulation of secondary immunoglobulin diversification.
Bello A, Hirth G, Voigt S, Tepper S, Jungnickel B
Cell Cycle. 2023; 22(18):2070-2087.
PMID: 37909747
PMC: 10761156.
DOI: 10.1080/15384101.2023.2275397.
Integration of spatial and single-cell data across modalities with weakly linked features.
Chen S, Zhu B, Huang S, Hickey J, Lin K, Snyder M
Nat Biotechnol. 2023; 42(7):1096-1106.
PMID: 37679544
PMC: 11638971.
DOI: 10.1038/s41587-023-01935-0.
APE2 Promotes AID-Dependent Somatic Hypermutation in Primary B Cell Cultures That Is Suppressed by APE1.
Schrader C, Williams T, Pechhold K, Linehan E, Tsuchimoto D, Nakabeppu Y
J Immunol. 2023; 210(11):1804-1814.
PMID: 37074207
PMC: 10234595.
DOI: 10.4049/jimmunol.2100946.
The transcriptional program during germinal center reaction - a close view at GC B cells, Tfh cells and Tfr cells.
Betzler A, Ushmorov A, Brunner C
Front Immunol. 2023; 14:1125503.
PMID: 36817488
PMC: 9936310.
DOI: 10.3389/fimmu.2023.1125503.
Discovering cell-active BCL6 inhibitors: effectively combining biochemical HTS with multiple biophysical techniques, X-ray crystallography and cell-based assays.
Pierrat O, Liu M, Collie G, Shetty K, Rodrigues M, Le Bihan Y
Sci Rep. 2022; 12(1):18633.
PMID: 36329085
PMC: 9633773.
DOI: 10.1038/s41598-022-23264-z.
ATR-mediated DNA damage responses underlie aberrant B cell activity in systemic lupus erythematosus.
Manolakou T, Nikolopoulos D, Gkikas D, Filia A, Samiotaki M, Stamatakis G
Sci Adv. 2022; 8(43):eabo5840.
PMID: 36306362
PMC: 9616496.
DOI: 10.1126/sciadv.abo5840.
B-cell Lymphoma 6 (BCL6): From Master Regulator of Humoral Immunity to Oncogenic Driver in Pediatric Cancers.
McLachlan T, Matthews W, Jackson E, Staudt D, Douglas A, Findlay I
Mol Cancer Res. 2022; 20(12):1711-1723.
PMID: 36166198
PMC: 9716245.
DOI: 10.1158/1541-7786.MCR-22-0567.
Developmental cell death of cortical projection neurons is controlled by a Bcl11a/Bcl6-dependent pathway.
Wiegreffe C, Wahl T, Joos N, Bonnefont J, Liu P, Britsch S
EMBO Rep. 2022; 23(8):e54104.
PMID: 35766181
PMC: 9346488.
DOI: 10.15252/embr.202154104.
DNA Damage Response and Repair in Adaptive Immunity.
Luo S, Qiao R, Zhang X
Front Cell Dev Biol. 2022; 10:884873.
PMID: 35663402
PMC: 9157429.
DOI: 10.3389/fcell.2022.884873.
The oncoprotein BCL6 enables solid tumor cells to evade genotoxic stress.
Liu Y, Feng J, Yuan K, Wu Z, Hu L, Lu Y
Elife. 2022; 11.
PMID: 35503721
PMC: 9064299.
DOI: 10.7554/eLife.69255.